TyG指数在心血管疾病中的研究进展
Research Progress of TyG Index in Cardiovascular Diseases
DOI: 10.12677/acm.2024.143908, PDF,   
作者: 王玉宁, 余 航:西安医学院研究生工作部,陕西 西安;胡小菁*:西安市第九医院心内科,陕西 西安
关键词: 甘油三酯–葡萄糖指数胰岛素抵抗心血管疾病TyG Insulin Resistance Cardiovascular Disease (CVD)
摘要: 甘油三酯葡萄糖指数(triglyceride-glucose index, TyG)作为一项胰岛素抵抗(insulin resistance, IR)替代标志物已逐渐被重视。近几年来,大量研究提供了有力的统计证据,证明TyG指数与心血管疾病(CVD)的发生、进展及预后具有重要的价值。但是,TyG指数作为CVD标志物还没有系统标准的评价,关于CVD相关的潜在机制的信息很少。本文总结了TyG指数作为IR替代标记物的历史。通过TyG在心血管疾病中的研究进展,旨在探讨TyG指数在多种CVD类型中的应用价值。
Abstract: Triglyceride-glucose index has been paid more and more attention, as an alternative marker of insulin resistance. In recent years, a large number of studies have provided strong statistical evidence that TyG index plays an important role in the occurrence, progression and prognosis of cardiovascular disease (CVD). However, as the evaluation standard of CVD marker system, TyG index has little information about the potential mechanism related to CVD. In this paper, we summarize the history of TyG index as a substitute marker for IR. Through the research progress of TyG in cardiovascular diseases, the purpose of this paper is to explore the application value of TyG index in many types of CVD.
文章引用:王玉宁, 余航, 胡小菁. TyG指数在心血管疾病中的研究进展[J]. 临床医学进展, 2024, 14(3): 1788-1794. https://doi.org/10.12677/acm.2024.143908

参考文献

[1] 胡盛寿, 高润霖, 刘力生, 等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019, 34(3): 209-220.
[2] Rosenblit, P.D. (2019) Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition. Current Diabetes Reports, 19, Article No. 61. [Google Scholar] [CrossRef] [PubMed]
[3] Choi, S. (2019) The Potential Role of Biomarkers Associated with ASCVD Risk: Risk-Enhancing Biomarkers. Journal of Lipid and Atherosclerosis, 8, 173-182. [Google Scholar] [CrossRef] [PubMed]
[4] Simental-Mendía, L.E., Rodríguez-Morán, M. and Guerrero-Romero, F. (2008) The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metabolic Syndrome and Related Disorders, 6, 299-304. [Google Scholar] [CrossRef] [PubMed]
[5] Steven, S., Frenis, K., Oelze, M., et al. (2019) Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 7092151. [Google Scholar] [CrossRef] [PubMed]
[6] Soewondo, P., Purnamasari, D., Oemardi, M., et al. (2010). Prevalence of Metabolic Syndrome Using NCEP/ATP III Criteria in Jakarta, Indonesia: The Jakarta Primary Non-Communicable Disease Risk Factors Surveillance 2006. Acta medica Indonesiana, 42, 199-203.
[7] Tao, L.C., Xu, J.N., Wang, T.T., et al. (2022) Triglyceride-Glucose Index as a Marker in Cardiovascular Diseases: Landscape and Limitations. Cardiovascular Diabetology, 21, Article No. 68. [Google Scholar] [CrossRef] [PubMed]
[8] Hill, M.A., Yang, Y., Zhang, L., et al. (2021) Insulin Resistance, Cardiovascular Stiffening and Cardiovascular Disease. Metabolism: Clinical and Experimental, 119, Article 154766. [Google Scholar] [CrossRef] [PubMed]
[9] Tahapary, D.L., Pratisthita, L.B., Fitri, N.A., et al. (2022) Challenges in the Diagnosis of Insulin Resistance: Focusing on the Role of HOMA-IR and Tryglyceride/Glucose Index. Diabetes & Metabolic Syndrome, 16, Article 102581. [Google Scholar] [CrossRef] [PubMed]
[10] Ramdas Nayak, V.K., Satheesh, P., Shenoy, M.T., et al. (2022) Triglyceride Glucose (TyG) Index: A Surrogate Biomarker of Insulin Resistance. The Journal of the Pakistan Medical Association, 72, 986-988. [Google Scholar] [CrossRef] [PubMed]
[11] Khan, S.H., Sobia, F., Niazi, N.K., et al. (2018) Metabolic Clustering of Risk Factors: Evaluation of Triglyceride-Glucose Index (TyG Index) for Evaluation of Insulin Resistance. Diabetology & Metabolic Syndrome, 10, Article No. 74. [Google Scholar] [CrossRef] [PubMed]
[12] Lee, E.Y., Yang, H.K., Lee, J., et al. (2016) Triglyceride Glucose Index, a Marker of Insulin Resistance, Is Associated with Coronary Artery Stenosis in Asymptomatic Subjects with Type 2 Diabetes. Lipids in Health and Disease, 15, Article No. 155. [Google Scholar] [CrossRef] [PubMed]
[13] Jin, J.L., Cao, Y.X., Wu, L.G., et al. (2018) Triglyceride Glucose Index for Predicting Cardiovascular Outcomes in Patients with Coronary Artery Disease. Journal of Thoracic Disease, 10, 6137-6146. [Google Scholar] [CrossRef] [PubMed]
[14] Liang, S., Wang, C., Zhang, J., et al. (2023) Triglyceride-Glucose Index and Coronary Artery Disease: A Systematic Review and Meta-Analysis of Risk, Severity, and Prognosis. Cardiovascular Diabetology, 22, Article No. 170. [Google Scholar] [CrossRef] [PubMed]
[15] Fernández-Friera, L., Fuster, V., López-Melgar, B., et al. (2017) Normal LDL-Cholesterol Levels Are Associated with Subclinical Atherosclerosis in the Absence of Risk Factors. Journal of the American College of Cardiology, 70, 2979-2991. [Google Scholar] [CrossRef] [PubMed]
[16] Park, G.M., Cho, Y.R., Won, K.B., et al. (2020) Triglyceride Glucose Index Is a Useful Marker for Predicting Subclinical Coronary Artery Disease in the Absence of Traditional Risk Factors. Lipids in Health and Disease, 19, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, J., Huang, X., Fu, C., et al. (2022) Association between Triglyceride Glucose Index, Coronary Artery Calcification and Multivessel Coronary Disease in Chinese Patients with Acute Coronary Syndrome. Cardiovascular Diabetology, 21, Article No. 187. [Google Scholar] [CrossRef] [PubMed]
[18] Wang, L., Cong, H.L., Zhang, J.X., et al. (2020) Triglyceride-Glucose Index Predicts Adverse Cardiovascular Events in Patients with Diabetes and Acute Coronary Syndrome. Cardiovascular Diabetology, 19, Article No. 80. [Google Scholar] [CrossRef] [PubMed]
[19] Luo, E., Wang, D., Yan, G., et al. (2019) High Triglyceride-Glucose Index Is Associated with Poor Prognosis in Patients with Acute ST-Elevation Myocardial Infarction after Percutaneous Coronary Intervention. Cardiovascular Diabetology, 18, Article No. 150. [Google Scholar] [CrossRef] [PubMed]
[20] Zhao, Q., Zhang, T.Y., Cheng, Y.J., et al. (2020) Impacts of Triglyceride-Glucose Index on Prognosis of Patients with Type 2 Diabetes Mellitus and Non-ST-Segment Elevation Acute Coronary Syndrome: Results from an Observational Cohort Study in China. Cardiovascular Diabetology, 19, Article No. 108. [Google Scholar] [CrossRef] [PubMed]
[21] Dong, S., Zhao, Z., Huang, X., et al. (2023) Triglyceride-Glucose Index Is Associated with Poor Prognosis in Acute Coronary Syndrome Patients with Prior Coronary Artery Bypass Grafting Undergoing Percutaneous Coronary Intervention. Cardiovascular Diabetology, 22, Article No. 286. [Google Scholar] [CrossRef
[22] Zhang, Y., Ding, X., Hua, B., et al. (2022) High Triglyceride-Glucose Index Is Associated with Poor Cardiovascular Outcomes in Nondiabetic Patients with ACS with LDL-C below 1.8 mmol/L. Journal of Atherosclerosis and Thrombosis, 29, 268-281. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, Y., Yang, W. and Jiang, X. (2021) Association between Triglyceride-Glucose Index and Hypertension: A Meta-Analysis. Frontiers in Cardiovascular Medicine, 8, Article 644035. [Google Scholar] [CrossRef] [PubMed]
[24] Gao, Q., Lin, Y., Xu, R., et al. (2023) Positive Association of Triglyceride-Glucose Index with New-Onset Hypertension among Adults: A National Cohort Study in China. Cardiovascular Diabetology, 22, Article No. 58. [Google Scholar] [CrossRef] [PubMed]
[25] Pang, J., Qian, L., Che, X., et al. (2023) TyG Index Is a Predictor of All-Cause Mortality during the Long-Term Follow-Up in Middle-Aged and Elderly with Hypertension. Clinical and Experimental Hypertension, 45, Article 2272581. [Google Scholar] [CrossRef] [PubMed]
[26] Xu, J., Xu, W., Chen, G., et al. (2023) Association of TyG Index with Prehypertension or Hypertension: A Retrospective Study in Japanese Normoglycemia Subjects. Frontiers in Endocrinology, 14, Article 1288693. [Google Scholar] [CrossRef] [PubMed]
[27] Ziaeian, B. and Fonarow, G.C. (2016) Epidemiology and Aetiology of Heart Failure. Nature Reviews Cardiology, 13, 368-378. [Google Scholar] [CrossRef] [PubMed]
[28] Khalaji, A., Behnoush, A.H., Khanmohammadi, S., et al. (2023) Triglyceride-Glucose Index and Heart Failure: A Systematic Review and Meta-Analysis. Cardiovascular Diabetology, 22, Article No. 244. [Google Scholar] [CrossRef] [PubMed]
[29] Campbell, P., Krim, S. and Ventura, H. (2015) The Bi-Directional Impact of Two Chronic Illnesses: Heart Failure and Diabetes—A Review of the Epidemiology and Outcomes. Cardiac Failure Review, 1, 8-10. [Google Scholar] [CrossRef] [PubMed]
[30] Cheng, H., Huang, W., Huang, X., et al. (2023) The Triglyceride Glucose Index Predicts Short-Term Mortality in Non-Diabetic Patients with Acute Heart Failure. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University, 33, 103-110. [Google Scholar] [CrossRef] [PubMed]
[31] Sun, T., Huang, X., Zhang, B., et al. (2023) Prognostic Significance of the Triglyceride-Glucose Index for Patients with Ischemic Heart Failure after Percutaneous Coronary Intervention. Frontiers in Endocrinology, 14, Article 1100399. [Google Scholar] [CrossRef] [PubMed]
[32] Guo, W., Zhao, L., Mo, F., et al. (2021) The Prognostic Value of the Triglyceride Glucose Index in Patients with Chronic Heart Failure and Type 2 Diabetes: A Retrospective Cohort Study. Diabetes Research and Clinical Practice, 177, Article 108786. [Google Scholar] [CrossRef] [PubMed]
[33] Cheang, I., Zhu, X., Lu, X., et al. (2024) Correlation of Ventricle Epicardial Fat Volume and Triglyceride-Glucose Index in Patients with Chronic Heart Failure. The International Journal of Cardiovascular Imaging. [Google Scholar] [CrossRef] [PubMed]